Although drugs targeting oncogenic driver mutations have significantly improved survival but their long-term responses are still uncommon for most patients, the emergence of acquired drug ...

The following is a summary of "Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact ...

The new technique, called STRACK, allows monitoring of the evolution of each cell before and after acquiring oncogenic mutations. Myeloid leukaemias are among the most aggressive blood cancers and ...

A new study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors ...

CAMBRIDGE, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic ...